Genomic and transcriptomic advances in amyotrophic lateral sclerosis.

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Amyotrophic lateral sclerosis (ALS) is a heterogeneous neurodegenerative motor neuron disease.
• Despite extensive research, effective treatments for ALS remain elusive.
• Multi-omic techniques are crucial for understanding ALS pathomechanisms.

Purpose of the Study:

• To provide a literature overview on omics approaches in ALS research.
• To explore the role of genomics, epigenomics, transcriptomics, and microRNAs in ALS.
• To identify potential biomarkers and therapeutic targets for ALS.

Main Methods:

• Literature review focusing on genomics, epigenomics, transcriptomics, and microRNAs in ALS.
• Analysis of high-throughput sequencing techniques (e.g., RNA sequencing).
• Discussion of microRNAs as biomarkers and therapeutic tools.

Main Results:

• Identified key genes implicated in ALS pathogenesis.
• Highlighted advancements in transcriptomic studies, including single-cell RNA sequencing.
• Emphasized the potential of microRNAs for diagnosis, prognosis, and intervention.

Conclusions:

• Multi-omic data integration is vital for uncovering ALS pathogenic pathways.
• Omics approaches can reveal diagnostic/prognostic biomarkers and patient subgroups.
• Novel therapeutic targets and effective treatments for ALS may emerge from integrated omics research.